BGNE 13F Hedge Fund and Asset Management Owners

Data based on most recent fiscal year report
Market Cap	7.514 Billion	Shares Outstanding	45.54 Million	Avg Volume	390.857 Thousand
1-Yr BETA vs S&P TR		Current Ratio	6.09	Quick Ratio	6.02

View SEC Filings from BGNE instead.

Q1 2019	All Institutions	Hedge Funds ¹
To trade BGNE now:
Filers who had this stock in their top 10:	9	3 (0.31%)
13F Filers holding this stock:	193	21 (2.14%)
Aggregate 13F shares on 03/31/2019:	48.545 Million	14.775 Million
Aggregate 13F shares on 12/31/2018:	47.673 Million	14.86 Million
Percent change:	1.83%	-0.57%
Funds creating new positions:	32	4
Funds Adding to an existing position:	69	4
Funds closing out their position:	25	4
Funds reducing their position:	54	5
¹ hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

BeiGene Ltd ADR Chart by YCharts

Yahoo! Finance

finviz

Check out our reporting and analysis

Abdiel Capital dislikes diversification -- the fund's 13F portfolio has returned 55% per year since 2015
via whalewisdomalpha 07/17/2019
The Tiger Cub hedge funds are killing it once again. 20 yrs after Tiger Management folded, its mystique endures.
via whalewisdomalpha 07/15/2019
Hedge Funds Have Been Piling into Microsoft’s Cheap Stock 07/15/2019
Orbimed Form 4 filing on Corvus Pharma ignited a 100% gain over 5 days
via whalewisdomalpha 07/08/2019
Starboard Value Wins Big with Symantec 07/08/2019
Archon filed a 13G on AquaBounty as Genetically Modified Salmon set to hit stores
via whalewisdomalpha 07/03/2019
The Baker Brothers’ Future Performance Rides on 5 Stocks 07/01/2019
Perceptive Advisors’ Big Bet in Array Pays Off 06/24/2019

Funds Holding BGNE (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Click for Additional Filters

Market Value:

Ranking:

% of portfolio

Refresh

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

14.3 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
OYLER JOHN CHIEF EXECUTIVE OFFICER	Officer Director	64,505,685	2019-07-08	6
WANG XIAODONG	Director CHAIR, SCIENTIFIC ADVISORY BRD	12,784,000	2019-07-01	8
BAKER BROS. ADVISORS LP 667, L.P. BAKER BROS. ADVISORS (GP) LLC BAKER BROTHERS LIFE SCIENCES LP BAKER FELIX BAKER JULIAN	Director 10% Owner	32,711,292	2019-06-28	1
LIANG HOWARD CFO & CHIEF STRATEGY OFFICER	Officer	122,317	2019-06-27	4
HUANG JANE CMO, HEMATOLOGY	Officer	328,873	2019-06-27	7
MALLEY THOMAS	Director	0	2019-06-25	1
YI QINGQING	Director	0	2019-06-17	2
BAKER BROS. ADVISORS LP 14159, L.P. 667, L.P. BAKER BROS. ADVISORS (GP) LLC BAKER BROTHERS LIFE SCIENCES LP BAKER FELIX BAKER JULIAN	Director 10% Owner	32,431,899	2019-06-06	1
GLAZER DONALD W.	Director	0	2019-06-05	5
CHEN TIMOTHY YUNG-CHENG	Director	0	2019-06-05	1
SU JINGSHYH S	Director	0	2019-06-05	1
WU XIAOBIN PRESIDENT & GM CHINA	Officer	1,509,956	2019-06-05	2
PETERSON AMY C. CMO, IMMUNO-ONCOLOGY	Officer	194,569	2018-12-17	3
LI JI EVP AND GL. HEAD OF BUS. DEV.	Officer	475,000	2018-02-28	0
HILLHOUSE CAPITAL MANAGEMENT, LTD.	10% Owner	71,139,367	2018-01-22	0
TANG KE	Director	0	2017-04-19	0
YANG JIANXIN SR. VP, HEAD OF CLINICAL DEV.	Officer	0	2016-07-13	0
YAN WENDY XIAOJUN SR. VP, HEAD OF REG. AFFAIRS	Officer	0	2016-07-13	0
MERCK & CO., INC. MERCK SHARP & DOHME CORP. MERCK SHARP & DOHME RESEARCH GMBH	10% Owner	31,589,038	2016-02-08	0
CB BIOTECH INVESTMENT LTD CPECHINA FUND, L.P. CITIC PE ASSOCIATES, L.P. CITIC PE FUNDS LTD	10% Owner	No longer subject to file	2016-02-08	0
YUAN RUIRONG CHIEF MEDICAL OFFICER	Officer	130,000	2016-02-08	0
KRISHANA RANJEEV	Director	0	2016-02-02	0
GOLLER MICHAEL	Director	0	2016-02-02	0

Insider Transactions Last 60 Days

Reporting Owners	Transaction Date	Transaction Code	Shares	Share Price	Acquired or Disposed	Shares Owned Following Transaction	Combined shares owned after filing	Direct/Indirect Ownership	10b-5
OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER	2019-07-08	S	100	$128.80	d	0	64,505,685.00	direct	yes
OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER	2019-07-08	S	1,200	$125.59	d	1,906	64,505,685.00	direct	yes
OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER	2019-07-08	S	1,087	$127.89	d	100	64,505,685.00	direct	yes
OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER	2019-07-08	S	719	$127.19	d	1,187	64,505,685.00	direct	yes
WANG XIAODONG - Director CHAIR, SCIENTIFIC ADVISORY BRD	2019-07-01	S	2,647	$126.73	d	0	12,784,000.00	direct	yes
WANG XIAODONG - Director CHAIR, SCIENTIFIC ADVISORY BRD	2019-07-01	S	2,200	$126.14	d	2,647	12,784,000.00	direct	yes
LIANG HOWARD - Officer CFO & CHIEF STRATEGY OFFICER	2019-06-27	S	5,876	$9.47	d	122,317	122,317.00	direct
HUANG JANE - Officer CMO, HEMATOLOGY	2019-06-27	S	3	$126.33	d	0	328,873.00	direct	yes
HUANG JANE - Officer CMO, HEMATOLOGY	2019-06-27	S	427	$124.50	d	3	328,873.00	direct	yes
YI QINGQING - Director	2019-06-17	J	9,282		d	0	0.00	direct
BAKER BROS. ADVISORS LP - Director - > 10% Owner 667, L.P. - Director - > 10% Owner BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner BAKER FELIX - Director - > 10% Owner BAKER JULIAN - Director - > 10% Owner	2019-06-06	J	43,109		a	43,109	17,089,476.00	direct
BAKER BROS. ADVISORS LP - Director - > 10% Owner 667, L.P. - Director - > 10% Owner BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner BAKER FELIX - Director - > 10% Owner BAKER JULIAN - Director - > 10% Owner	2019-06-06	J	13,516		a	20,618	17,089,476.00	direct
BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes 667, L.P. - Director - > 10% Owner see footnotes BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes BAKER FELIX - Director - > 10% Owner see footnotes BAKER JULIAN - Director - > 10% Owner see footnotes	2019-06-06	J	582,200		d	18,591	17,089,476.00	indirect
BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes 667, L.P. - Director - > 10% Owner see footnotes BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes BAKER FELIX - Director - > 10% Owner see footnotes BAKER JULIAN - Director - > 10% Owner see footnotes	2019-06-06	J	182,539		d	1,028,034	17,089,476.00	indirect
BAKER BROS. ADVISORS LP - Director - > 10% Owner 667, L.P. - Director - > 10% Owner BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner BAKER FELIX - Director - > 10% Owner BAKER JULIAN - Director - > 10% Owner	2019-06-06	J	43,109		a	43,109	17,089,476.00	direct
BAKER BROS. ADVISORS LP - Director - > 10% Owner 667, L.P. - Director - > 10% Owner BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner BAKER FELIX - Director - > 10% Owner BAKER JULIAN - Director - > 10% Owner	2019-06-06	J	13,516		a	20,618	17,089,476.00	direct
OYLER JOHN - Director - Officer CHIEF EXECUTIVE OFFICER	2019-06-05	A	2,193,282		a	2,193,282	0.00	direct
HUANG JANE - Officer CMO, HEMATOLOGY	2019-06-05	A	62,842		a	334,463	334,463.00	direct
SU JINGSHYH S - Director	2019-06-05	A	64,610		a	64,610	0.00	direct
CHEN TIMOTHY YUNG-CHENG - Director	2019-06-05	A	64,610		a	64,610	0.00	direct
GLAZER DONALD W. - Director	2019-06-05	A	64,610		a	64,610	0.00	direct
YI QINGQING - Director	2019-06-05	A	64,610		a	64,610	0.00	direct
LIANG HOWARD - Officer CFO & CHIEF STRATEGY OFFICER	2019-06-05	A	558,285		a	558,285	128,193.00	direct
BAKER BROS. ADVISORS LP - Director - > 10% Owner see footnotes 667, L.P. - Director - > 10% Owner see footnotes BAKER BROS. ADVISORS (GP) LLC - Director - > 10% Owner see footnotes BAKER BROTHERS LIFE SCIENCES LP - Director - > 10% Owner see footnotes BAKER FELIX - Director - > 10% Owner see footnotes BAKER JULIAN - Director - > 10% Owner see footnotes	2019-06-05	A	129,220		a	129,220	17,089,476.00	indirect
WU XIAOBIN - Officer PRESIDENT & GM CHINA	2019-06-05	A	797,550		a	797,550	1,509,956.00	direct
MALLEY THOMAS - Director	2019-06-05	A	64,610		a	64,610	0.00	direct
HUANG JANE - Officer CMO, HEMATOLOGY	2019-06-05	A	462,579		a	462,579	334,463.00	direct
LIANG HOWARD - Officer CFO & CHIEF STRATEGY OFFICER	2019-06-05	A	75,855		a	128,193	128,193.00	direct
WANG XIAODONG - Director CHAIR, SCIENTIFIC ADVISORY BRD	2019-06-05	A	747,708		a	747,708	0.00	direct
WU XIAOBIN - Officer PRESIDENT & GM CHINA	2019-06-05	A	433,472		a	1,505,956	1,509,956.00	direct

Click here to report any possible errors with this stock listing.

BeiGene Ltd ADR (BGNE)

Check out our reporting and analysis

Funds Holding BGNE (via 13F filings)

Filter by:

Active Schedule 13D and 13G filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

Elevate your investments

BeiGene Ltd ADR (BGNE)

Check out our reporting and analysis

Funds Holding BGNE (via 13F filings)

Filter by:

Active Schedule 13D and 13G filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

Report an error

Elevate your investments